Steward Partners Investment Advisory’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Steward Partners Investment Advisory’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,250	Closed	-$2.16K	–	3479
2023 Q2	$2.16K	Hold	2,250	–	–	﹤0.01%	3017
2023 Q1	$1.69K	Hold	2,250	–	–	﹤0.01%	3049
2022 Q4	$829	Hold	2,250	–	–	﹤0.01%	3140
2022 Q3	$1K	Hold	2,250	–	–	﹤0.01%	3201
2022 Q2	$2K	Hold	2,250	–	–	﹤0.01%	3063
2022 Q1	$3K	Hold	2,250	–	–	﹤0.01%	3054
2021 Q4	$3K	Hold	2,250	–	–	﹤0.01%	2990
2021 Q3	$5K	Sell	2,250 -500	-18%	-$1.37K	﹤0.01%	2835
2021 Q2	$10K	Buy	2,750 +500	+22%	+$1.74K	﹤0.01%	6075
2021 Q1	$7.33K	Hold	2,250	–	–	﹤0.01%	2893
2020 Q4	$8K	Hold	2,250	–	–	﹤0.01%	2394
2020 Q3	$9K	Hold	2,250	–	–	﹤0.01%	2201
2020 Q2	$8K	Buy	+2,250	New	+$6.56K	﹤0.01%	2140

Steward Partners Investment Advisory's SPPI Position: Q3 2023 in Review

Steward Partners Investment Advisory sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 2,250 shares — an estimated $2.16K sold.

Steward Partners Investment Advisory first reported a position in SPPI in Q2 2020 and held it in 13 quarters. The position peaked at $10K in Q2 2021. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.

Steward Partners Investment Advisory reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
Steward Partners Investment Advisory sold 2,250 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $2.16K.
Steward Partners Investment Advisory first reported a position in Spectrum Pharmaceuticals Inc in Q2 2020 and held it in 13 quarters.
Steward Partners Investment Advisory's Spectrum Pharmaceuticals Inc position peaked at $10K in Q2 2021.
0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.

Based on Steward Partners Investment Advisory's 13F filing for Q3 2023, filed 13 Nov 2023.